Anthem Biosciences IPO: Rs 3,395 crore IPO to open on July 14

Anthem Biosciences’ Rs 3,395 crore IPO will open on July 14 as a complete Offer for Sale by promoters and investors. The Bengaluru-based CRDMO firm provides integrated drug development and manufacturing services across advanced technology platforms and modalities.

Adani Group on track to complete $5 billion fundraising blitz in FY26

The Adani Group is storming back into global capital markets with unstoppable momentum, having already raised over $3.2 billion in just six months and positioning itself to complete a massive $5 billion fundraising blitz by FY26, a stunning validation of its infrastructure-first strategy amid relentless scrutiny.

Jane Street saga: Nilesh Shah gives 3 reasons why no HFT will do it in China

Kotak MF’s Nilesh Shah warned that India’s capital markets are exposed to HFT manipulation due to regulatory gaps. Comparing India to China, he proposed five urgent reforms—from stronger enforcement to financial literacy—to counter potential threats like Jane Street and protect retail investors from unchecked speculation and systemic manipulation.

10 Nifty largecaps with up to 38 buy calls; analysts see up to 20% upside

Brokerages remain bullish on select Nifty large-cap stocks across sectors, with several companies receiving over 30 ‘buy’ calls from analysts, according to Trendlyne data. These include blue-chip names such as HDFC Bank, SBI, Reliance Industries, M&M, and Axis Bank, with analysts projecting up to 20% upside from current levels.

Gold prices may tumble up to Rs 94,950/10 grams. Should you book profit?

Gold futures opened lower at MCX due to Trump’s new tariffs, while silver saw a slight increase. Market volatility is expected this week amid dollar index fluctuations and upcoming US trade deal deadlines. Experts suggest monitoring key support and resistance levels for both gold and silver, with potential buying opportunities on dips for silver.

FMCG could see earnings upgrade, but valuation still a concern: Nitin Bhasin

Nitin Bhasin from Ambit suggests caution on midcap IT firms like Coforge and Persistent due to high valuations, along with DMart and Voltas. While FMCG valuations remain rich, domestic companies like GCPL are favored. Bhasin also expresses concern over expensive defense stocks and Godrej Real Estate, highlighting the importance of earnings expectations alongside valuations.